All posts

Converge Technology has an 88 per cent upside, says Eight Capital

A new tuck-in acquisition looks good on Converge Technology Solutions (Converge Technology Solutions Stock Quote, Charts, News, Analysts, Financials TSX:CTS), according Christian Sgro, analyst for Eight Capital. In a Monday update, Sgro reiterated a “Buy” rating and $11.00 target price on Converge, saying the acquisition will generate some good synergies with Converge’s existing operations.

Canadian IT solutions provider Converge Technology announced on Monday the acquisition of Toronto-based Newcomp Analytics in a $20.3 million deal. Newcomp has advisory and development services to help businesses manage their data strategies. The company has business in North America and works with large data vendors like Microsoft and Alteryx and has brand-name customers like DHL and Clorox.

The acquisition represents the 34th pickup by Converge and its affiliates since 2017.

“Converge is excited to expand our advanced analytics portfolio and offerings with the addition of Newcomp Analytics,” said Greg Berard, President and North American CEO of Converge, in a press release. “Newcomp Analytics will greatly enhance Converge’s ability to help our clients become even more insight-driven and dive deeper into understanding and analyzing their data.”

Looking at the deal, Sgro noted that Newcomp has trailing 12 months gross revenue of $36.4 million and adjusted EBITDA of $3.4 million, putting the $20.3 million purchase price at 6x EBITDA, which is at the higher end of Converge’s range. 

But Sgro said the acquisition still looks attractive due to the higher value analytics offering presented by Newcomp along with the company’s managed services component and strong margin profile. Overall, Sgro said the impact of the deal was “slightly positive” for Converge.

“Despite the smaller size we see the announcement as incrementally positive given the following: 1) data analytics focus as an attractive end market, 2) managed services component and margin profile, and 3) negligible impact on overall debt and leverage, providing flexibility for continued and larger M&A,” Sgro wrote.

“Newcomp counts 80+ employees which will add to Converge’s analytics capabilities and managed services teams. We expect it will be difficult to attract talent in these areas as Converge scales in North America. Newcomp also hosts customer workshops as part of its go-to-market strategy, complementary to Converge’s strategy,” he said.

Looking ahead, Sgro said with an updated net debt balance of $215.5 million, Converge still has ample capacity for a UK platform acquisition, something the analyst sees as part of the European plan for Converge. 

“Given that Converge has effectively met its +$1 billion annual gross revenue M&A target in 2022, we believe Converge can be strategic/disciplined on timing, the purchase price, and cultural alignment,” he said.

With a market cap of $1.3 billion, CTS was a clear winner over the first stretch of the pandemic, where the stock returned 670 per cent over 2020 and 2021 combined. But the market pullback this year has dropped CTS from a high of $12.85 per share last September to now just under $6.

Sgro’s 12-month target of $11.00 represented at press time a projected return of 88.0 per cent.

Last week, Converge Technology reported its second quarter 2022 financials, featuring gross revenues up 61 per cent year-over-year to $729.7 million and adjusted EBITDA up 80 per cent to $39.2 million. Adjusted EPS went from $0.08 per share a year ago to $0.14 per share. 

We Hate Paywalls Too!

At Cantech Letter we prize independent journalism like you do. And we don't care for paywalls and popups and all that noise That's why we need your support. If you value getting your daily information from the experts, won't you help us? No donation is too small.

Make a one-time or recurring donation

Tagged with: cts
Staff

Recent Posts

These cannabis stocks will benefit most from reclassification

It happened. The move that everyone in the cannabis sector was hoping for came about swiftly on the last day… [Read More]

5 hours ago

Is AMD stock a buy? (May, 2024)

Following the company's first quarter results, Roth MKM analyst Suji Desilva has maintained his "Buy" rating on Advanced Micro Devices… [Read More]

6 hours ago

Is Wolfspeed stock still a buy?

Ahead of the company's third quarter results, Roth MKM analyst Scott Irwin has maintained his "Buy" rating on Wolfspeed (Wolfspeed… [Read More]

7 hours ago

WELL Health inks five-year deal with Microsoft

It's become one of the biggest players in the Canadian healthcare space, now WELL Health (WELL Health Stock Quote, Chart,… [Read More]

1 day ago

Is Thomson Reuters stock a buy right now?

Its stock has made a since last October, but is there more upside left in Thomson Reuters (Thomson Reuters Stock… [Read More]

1 day ago

Is GOOGL still a buy?

Following a widely applauded first quarter beat, Roth MKM analyst Rohit Kulkarni has maintained his "Buy" rating on Alphabet (Alphabet… [Read More]

2 days ago